Evidence map›Paper›PMID 35487761›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2022

Co-Electrospun Silk Fibroin and Gelatin Methacryloyl Sheet Seeded with Mesenchymal Stem Cells for Tendon Regeneration.

Yumeng Xue, Han-Jun Kim, Junmin Lee, Yaowen Liu, Tyler Hoffman, Yi Chen, Xingwu Zhou, Wujin Sun, Shiming Zhang, Hyun-Jong Cho and 9 more

Open access · greenAbstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Grafts in tendon repair.Materials today. Bio · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Tendon mechanobiology in the context of tendon biofabrication.Frontiers in bioengineering and biotechnology · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Regenerative biomaterials · 2024
    Article
  15. Reprogramming tendon healing: a guide to novel molecular tools.Frontiers in bioengineering and biotechnology · 2024
    Review
  16. Article
  17. Review
  18. Review
  19. Three-Dimensional Cell Culture System for Tendon Tissue Engineering.Tissue engineering and regenerative medicine · 2023
    Review
  20. Biomimetic Scaffolds for Tendon Tissue Regeneration.Biomimetics (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Yumeng XueState Key Laboratory of Solidification Processing, Center for Nano Energy Materials, School of Materials Science and Engineering, Northwestern Polytechnical University, Xi'an, 710072, China.
Han-Jun KimDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.ORCID 0000-0001-9238-7238
Junmin LeeDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.
Yaowen LiuDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.
Tyler HoffmanDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.
Yi ChenDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.
Xingwu ZhouDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.
Wujin SunDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.
Shiming ZhangDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.
Hyun-Jong ChoCollege of Pharmacy, Kangwon National University, Chuncheon, 24341, Republic of Korea.
JiYong LeeDepartment of Mechanical Engineering, Yonsei University, Seoul, 03722, Republic of Korea.
Heemin KangDepartment of Materials Science and Engineering, Korea University, Seoul, 02841, Republic of Korea.
WonHyoung RyuDepartment of Mechanical Engineering, Yonsei University, Seoul, 03722, Republic of Korea.
Chang-Moon LeeSchool of Healthcare and Biomedical Engineering, Chonnam National University, Yeosu, 59626, Republic of Korea.
Samad AhadianDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.
Mehmet R DokmeciDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.
Bo LeiFrontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710054, China.
KangJu LeeDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.
Ali KhademhosseiniDepartment of Bioengineering and Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, 90095, USA.ORCID 0000-0002-2692-1524
University of California, Los Angeles · USChonnam National University · KRYonsei University · KRKangwon National University · KRKorea University · KRXi'an Jiaotong University · CN

Funding

Rapid 3D bioprinting of biomimetic vascularized tissue constructsR01EB021857 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, SHAOCHEN, DOKMECI, MEHMET REMZI · 2016 to 2019
$2.1M
Smart wound dressing for treating chronic diabetic ulcersR21EB022403 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI KHADEMHOSSEINI, ALI · 2016 to 2017
$484k
NIBIB NIH HHS R01 EB021857NIBIB NIH HHS R21 EB022403NIH HHS EB022403NIH HHS R01EB021857
6 · The paper itself

Abstract

Silk fibroin (SF) is a promising biomaterial for tendon repair, but its relatively rigid mechanical properties and low cell affinity have limited its application in regenerative medicine. Meanwhile, gelatin-based polymers have advantages in cell attachment and tissue remodeling but have insufficient mechanical strength to regenerate tough tissue such as tendons. Taking these aspects into account, in this study, gelatin methacryloyl (GelMA) is combined with SF to create a mechanically strong and bioactive nanofibrous scaffold (SG). The mechanical properties of SG nanofibers can be flexibly modulated by varying the ratio of SF and GelMA. Compared to SF nanofibers, mesenchymal stem cells (MSCs) seeded on SG fibers with optimal composition (SG7) exhibit enhanced growth, proliferation, vascular endothelial growth factor production, and tenogenic gene expression behavior. Conditioned media from MSCs cultured on SG7 scaffolds can greatly promote the migration and proliferation of tenocytes. Histological analysis and tenogenesis-related immunofluorescence staining indicate SG7 scaffolds demonstrate enhanced in vivo tendon tissue regeneration compared to other groups. Therefore, rational combinations of SF and GelMA hybrid nanofibers may help to improve therapeutic outcomes and address the challenges of tissue-engineered scaffolds for tendon regeneration.

Indexed as

FibroinsMesenchymal Stem CellsNanofibersCell ProliferationGelatinMethacrylatesSilkTendonsTissue EngineeringTissue ScaffoldsVascular Endothelial Growth Factor AFibroinsGelatingelatin methacryloylMethacrylatesSilkVascular Endothelial Growth Factor Aelectrospinninggelatin methacryloylmesenchymal stem cellssilk fibrointendon regeneration

Identifiers

PMID35487761
PMCPMC9714686
OpenAlexW4225151975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.